III:LSE-3i Group plc (GBX)

COMMON STOCK | Asset Management | LSE

Last Closing Price

GBX 1,046.50

Change

-20.50 (-1.92)%

Market Cap

GBX 10.18B

Volume

0.95M

Average Target Price

GBX 1,085.00 (+3.68%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; and leisure. In the healthcare sector, the firm focuses on pharmaceuticals and biotechnology including specialty pharma, generics / OTC, drug delivery, and animal health; healthcare Services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, clinical services and B2B contract services; medical devices and technology including devices, medical equipment and consumables, diagnostics, and healthcare IT. In the industrial sector, it focuses on automotive, chemicals, construction and building products, electronics and electrical components, flow control and filtr Address: 16 Palace Street, London, United Kingdom, SW1E 5JD

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-10-26 )

Largest Industry Peers for Asset Management

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SDRC:LSE Schroders plc

+6.00 (+0.33%)

GBX8.98B 11.35 8.45
SDR:LSE Schroders plc

-50.00 (-1.79%)

GBX8.79B 17.24 8.45
HL:LSE Hargreaves Lansdown plc

-36.50 (-2.58%)

GBX6.53B 21.41 15.93
SLA:LSE Standard Life Aberdeen plc

-9.50 (-3.92%)

GBX5.17B 29.94 N/A
MNG:LSE M&G plc

-2.55 (-1.51%)

GBX4.39B 3.98 N/A
ICP:LSE Intermediate Capital Group plc

-37.00 (-2.86%)

GBX3.69B 33.85 9.45
HICL:LSE HICL Infrastructure PLC Ord

-0.60 (-0.34%)

GBX3.40B 62.96 N/A
RCP:LSE RIT Capital Partners plc

-16.00 (-0.83%)

GBX2.99B 103.98 N/A
PCT:LSE Polar Capital Technology Trust

-15.00 (-0.69%)

GBX2.95B 8.23 N/A
INPP:LSE International Public Partnersh..

-1.20 (-0.70%)

GBX2.74B 29.23 N/A

ETFs Containing III

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Asset Management)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.69% 64% D 52% F
Dividend Return 1.59% 43% F 52% F
Total Return -3.10% 60% D- 53% F
Trailing 12 Months  
Capital Gain -7.39% 50% F 43% F
Dividend Return 1.55% 40% F 41% F
Total Return -5.84% 47% F 43% F
Trailing 5 Years  
Capital Gain 107.43% 91% A- 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 107.43% 87% B+ 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 20.20% N/A N/A 82% B-
Dividend Return 0.12% N/A N/A 25% F
Total Return 20.32% N/A N/A 81% B-
Risk Return Profile  
Volatility (Standard Deviation) 28.75% N/A N/A 36% F
Risk Adjusted Return 70.70% N/A N/A 79% C+
Market Capitalization 10.18B 100% A+ 98% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Asset Management)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 47.74 15% F 16% F
Price/Book Ratio 1.32 18% F 45% F
Price / Cash Flow Ratio 60.26 14% F 5% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 2.73% 55% F 55% F
Return on Invested Capital -0.01% 61% D- 40% F
Return on Assets 1.48% 56% F 51% F
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.06 17% F 31% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector